About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Cutaneous Leishmaniasis: A Case Report from Eastern part of Indian Subcontinent
Rajesh Sinha1, Pinki Kumari2, Abhijeet Kumar Jha1
1Department of Dermatology, STD & Leprosy; All India Institute of Medical Sciences, Patna; 2Department of Ophthalmology, Patna Medical College, Patna, Bihar, India.
Corresponding Author:
Dr. Rajesh Sinha
Email: sinhaderma@gmail.com   
Received: 26-DEC-2015 Accepted: 07-MAR-2016 Published Online: 15-APR-2016
DOI: http://dx.doi.org/10.17659/01.2016.0039
Abstract
Cutaneous Leishmaniasis is rare in eastern part of Indian subcontinent, although visceral leishmaniasis is common in this region. It has been mainly reported in north-western part (Rajasthan and adjoining areas) of this region. Here in we report a case of cutaneous leishmaniasis who presented in the outpatient department of All India Institute of Medical Sciences, Patna.
Keywords : Cutaneous Leishmaniasis, Visceral Leishmaniasis, Phelobotomus, Protozoan Infections.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024